Glaucoma, but not cataracts, predicts lower verbal fluency performance: 3.8-year follow-up from the ELSA-Brasil study

Imagem de Miniatura
Arquivos
art_VIDAL_Glaucoma_but_not_cataracts_predicts_lower_verbal_fluency_2021.PDF (787.23 KB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2021
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
Autores
MORENO, Arlinda B.
DUNCAN, Bruce
SCHMIDT, Maria Ines
MAESTRI, Marcelo
BARRETO, Sandhi M.
Citação
AGING NEUROPSYCHOLOGY AND COGNITION, v.28, n.6, p.871-883, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Glaucoma, cataracts, and cognitive decline are most common in older ages. Although cross-sectional studies showed that these disorders are associated, follow-up studies are lacking. To investigate this issue, baseline and follow-up data from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) were employed. We evaluated participants >= 55 years-old at follow-up without diagnosis of dementia, stroke, and other eye conditions except for glaucoma and cataracts. Cognition was evaluated using delayed word recall, verbal fluency, and trail making (version B) tests. Regression models were employed to investigate associations between glaucoma and cognition, adjusted by several confounders. Out of 3,867 participants, 379 and 118 presented cataracts and glaucoma, respectively. Only glaucoma was apredictor of lower verbal fluency (B = -0.23, 95% CI -035 to -012, p< 0.001). Other associations were not significant (ps>0.57). Our results suggest that glaucoma may be related to declining cognition.
Palavras-chave
Cohort study, verbal fluency, glaucoma, cataracts, cognition, eye diseases
URI
https://observatorio.fm.usp.br/handle/OPI/42083
Referências
  1. Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
  2. Ascaso FJ, 2014, J NEUROL, V261, P1522, DOI 10.1007/s00415-014-7374-z
  3. Bourne RRA, 2018, BRIT J OPHTHALMOL, V102, P575, DOI 10.1136/bjophthalmol-2017-311258
  4. Brunoni AR, 2020, J AFFECT DISORDERS, V263, P252, DOI 10.1016/j.jad.2019.11.155
  5. Chor Dóra, 2013, Rev. Saúde Pública, V47, P27, DOI 10.1590/S0034-8910.2013047003835
  6. Chung SD, 2015, EYE, V29, P1340, DOI 10.1038/eye.2015.120
  7. Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
  8. Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241
  9. Ekstrom C, 2017, ACTA OPHTHALMOL, V95, pE157, DOI 10.1111/aos.13243
  10. Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238
  11. Frezzotti P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105931
  12. Fukuoka H, 2016, CURR OPIN OPHTHALMOL, V27, P3, DOI 10.1097/ICU.0000000000000226
  13. Hassan B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216492
  14. Helmer C, 2013, ANN NEUROL, V74, P171, DOI 10.1002/ana.23926
  15. Hinton-Bayre AD, 2010, ARCH CLIN NEUROPSYCH, V25, P244, DOI 10.1093/arclin/acq008
  16. Ioannidis JPA, 2018, JAMA-J AM MED ASSOC, V319, P1429, DOI 10.1001/jama.2018.1536
  17. James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]
  18. Jefferis JM, 2011, BRIT J OPHTHALMOL, V95, P17, DOI 10.1136/bjo.2009.165902
  19. Jefferis JM, 2013, OPHTHAL EPIDEMIOL, V20, P82, DOI 10.3109/09286586.2012.757626
  20. Jonas JB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23314-5
  21. Leasher JL, 2019, BRIT J OPHTHALMOL, V103, P885, DOI 10.1136/bjophthalmol-2017-311746
  22. Lee CS, 2019, ALZHEIMERS DEMENT, V15, P34, DOI 10.1016/j.jalz.2018.06.2856
  23. Li T, 2015, INT J ENVIRON POLLUT, V56, P1, DOI 10.1504/IJEP.2014.067672
  24. Liu YC, 2017, LANCET, V390, P600, DOI 10.1016/S0140-6736(17)30544-5
  25. Michael R, 2013, EXP EYE RES, V106, P5, DOI 10.1016/j.exer.2012.10.012
  26. Moncaster J. A., 2010, ALZHEIMERS DEMENTI S, V20, P10659, DOI 10.1016/j.jalz.2010.08.070
  27. Nunes M. A., 2011, REV HCPA, V31, P487
  28. Ou Y, 2012, OPHTHAL EPIDEMIOL, V19, P285, DOI 10.3109/09286586.2011.649228
  29. Piccinelli M, 1997, BRIT MED J, V314, P420, DOI 10.1136/bmj.314.7078.420
  30. Sakata K, 2007, INVEST OPHTH VIS SCI, V48, P4974, DOI 10.1167/iovs.07-0342
  31. Schmidt MI, 2013, REV SAUDE PUBL, V47, P105, DOI 10.1590/S0034-8910.2013047003889
  32. Shao Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00772
  33. Su CW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002833
  34. Varin M, 2020, OPHTHALMOLOGY, V127, P660, DOI 10.1016/j.ophtha.2019.10.004
  35. Wang BS, 2018, BRIT J OPHTHALMOL, V102, P220, DOI 10.1136/bjophthalmol-2017-310333
  36. Wang JQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18969
  37. Wareham LK, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00452
  38. Xiao ZX, 2020, J ALZHEIMERS DIS, V76, P529, DOI 10.3233/JAD-200295

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - LIM/20
Artigos e Materiais de Revistas Científicas - LIM/27
Artigos e Materiais de Revistas Científicas - LIM/66
Artigos e Materiais de Revistas Científicas - ODS/03